Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
2:00 p.m. |
Call to Order Nora Volkow, M.D., Director, NIDA Review of and Policy Procedures Teresa Levitin, Ph.D., Executive Secretary, National Advisory Council on Drug Abuse, NIDA |
2:15 p.m. |
Council Review of Grant Applications Nora Volkow, M.D., Director, NIDA Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA) Division of Basic Neuroscience and Behavioral Research (DBNBR) |
4:00 p.m. | Adjourn |
8:30 a.m. |
Opening and Director's Report Nora Volkow, M.D. Director, NIDA |
9:30 a.m. |
Council Discussion Council Members |
10:00 a.m. |
Break
|
10:30 a.m. |
Medication Trials in Stimulant Dependence: An Update
David McCann, Ph.D.
Associate Director
Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
|
11:00 a.m. |
Adoption of NIDA's Evidence Based Treatments Workgroup Recommendations
Caryn Lerman, Ph.D.
Council Workgroup Chair and Mary W. Calkins Professor
University of Pennsylvania
|
11:45 a.m. |
Update on Loan Repayment Program
Susan Weiss, Ph.D.
Associate Director for Scientific Affairs, Office of the Director, NIDA
|
12:15 p.m. |
AIDS Program and International AIDS
Jacques Normand, Ph.D.
Director, AIDS Research Program (ARP)
|
12:45 p.m. | Public Comments |
1:00 p.m. | Adjourn |